Cardinal Health (CAH) Rises Yet Lags Behind Market: Some Facts Worth Knowing
Cardinal Health (CAH) reachead $118.83 at the closing of the latest trading day, reflecting a +0.41% change compared to its last close.
Is Cardinal Health (CAH) a Great Value Stock Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Strength Across Segments to Help CAH Stock Offset OptumRx Headwind?
CAH gains from a solid pharmaceutical segment and a diversified product portfolio. However, concentrated revenue generation and regulatory setbacks are a concern.
Cardinal Health, Inc. (CAH) Annual Evercore ISI HealthCONx Healthcare Conference (Transcript)
Cardinal Health, Inc. (NYSE:CAH ) Annual Evercore ISI HealthCONx Healthcare Conference December 3, 2024 1:30 PM ET Company Participants Matt Sims - VP, IR Aaron Alt - CFO Conference Call Participants Elizabeth Anderson - Evercore ISI Elizabeth Anderson Hi, everybody. Thanks so much for joining us today.
Cardinal Health, Inc. (CAH) Citi's 2024 Global Healthcare Conference (Transcript)
Cardinal Health, Inc. (NYSE:CAH ) Citi's 2024 Global Healthcare Conference Call December 3, 2024 8:00 AM ET Company Participants Aaron Alt - Chief Financial Officer Matt Sims - Head, Investor Relations Conference Call Participants Daniel Grosslight - Citi Daniel Grosslight Thanks for joining us for the Cardinal Health fireside chat here at Citi's Global Healthcare Conference. My name is Daniel Grosslight.
Should Value Investors Buy Cardinal Health (CAH) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
CAH Stock Gains on the Launch of Kendall SmartFlow Compression System
Cardinal Health launches the next generation of the Kendall Compression Series, Kendall SCD SmartFlow Compression System, to aid pain relating to venous stasis.
Cardinal Health, Inc. (CAH) UBS Global Healthcare Conference (Transcript)
Cardinal Health, Inc. (NYSE:CAH ) UBS Global Healthcare Conference November 12, 2024 11:00 AM ET Company Participants Matt Sims - Vice President, Investor Relations Aaron Alt - Chief Financial Officer Conference Call Participants Kevin Caliendo - UBS Kevin Caliendo Good morning, everybody. Welcome to the UBS Healthcare Global Healthcare Conference.
Cardinal Health Stock Gains Following Two Strategic Acquisitions
CAH announces two strategic acquisitions to strengthen its multi-specialty and at-Home Solutions businesses.
Is Cardinal Health (CAH) Outperforming Other Medical Stocks This Year?
Here is how Cardinal Health (CAH) and Adaptive Biotechnologies (ADPT) have performed compared to their sector so far this year.
Are Investors Undervaluing Cardinal Health (CAH) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
